+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Peptide Synthesis Market by Product, Technology, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4896703
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Peptide Synthesis Market grew from USD 636.71 million in 2023 to USD 683.44 million in 2024. It is expected to continue growing at a CAGR of 7.84%, reaching USD 1.08 billion by 2030.

Peptide synthesis is the chemical creation of peptides, which are short chains of amino acids linked by peptide bonds. The scope encompasses solid-phase synthesis, liquid-phase synthesis, and hybrid methods applicable in pharmaceuticals, biotechnology, diagnostics, and academic research. Its necessity is underscored by peptides’ crucial roles in drug development, therapeutic agents, and diagnostic applications, owing to their high specificity and efficacy in targeting disease pathways. The end-use scope spans pharmaceuticals, biotechnology companies, academic institutes, and contract research organizations. Key factors driving market growth include advancements in peptide synthesis technologies, increased demand for peptide-based therapeutics in chronic disease treatment, and growing investment in R&D. Noteworthy opportunities lie in personalized medicine, where peptide therapeutics offer targeted treatment options. To seize these opportunities, firms should invest in hybrid synthesis methods and automation to boost efficiency and scalability. However, the market faces limitations like the high cost of synthesis, complexity in large-scale production, and regulatory hurdles. Difficulties also arise from issues in peptide stability and delivery mechanisms. Innovation efforts should focus on improving synthesis methods for cost reduction, enhancing peptide stability, and developing novel delivery systems to overcome these challenges. Adopting bioinformatics and computational tools for streamlined peptide design can also drive advancement. Further research into sustainable and less toxic synthetic methods would benefit market expansion. The market is characterized by robust competition, reflecting continuous technological advancements and collaborations between pharmaceutical giants and research institutions. Thus, understanding current market trends and emerging technologies, while closely monitoring regulatory landscapes, is vital. Investing in high-growth regions and fostering strategic partnerships for expertise and resource sharing may yield competitive advantages for companies aiming to lead in the peptide synthesis market.

Understanding Market Dynamics in the Peptide Synthesis Market

The Peptide Synthesis Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Higher need and applications of peptide therapeutics
    • Increase in pharmaceutical research activities and funding across economies
    • Growing demand for bioactive peptides from the cosmetics industry
  • Market Restraints
    • Lack of standard peptide design rules and regulations
  • Market Opportunities
    • Development of advanced peptide synthesizers and technologies for peptide design
    • Emerging applications of peptides in nutraceuticals and food preservation
  • Market Challenges
    • Difficulty in development of peptides and instability of the peptides

Exploring Porter’s Five Forces for the Peptide Synthesis Market

Porter’s Five Forces framework further strengthens the insights of the Peptide Synthesis Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Peptide Synthesis Market

External macro-environmental factors deeply influence the performance of the Peptide Synthesis Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Peptide Synthesis Market

The Peptide Synthesis Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Peptide Synthesis Market

The Peptide Synthesis Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Peptide Synthesis Market

The Peptide Synthesis Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Peptide Synthesis Market, highlighting leading vendors and their innovative profiles. These include 2B Scientific Limited, AAPPTec, ABclonal, Inc., Advanced ChemTech, Almac Group Limited, AmbioPharm Inc., AnaSpec Inc., Bachem AG, Biocon Limited, Biosynth Ltd., Biotage, CEM Corporation, CPC Scientific Inc., Creative Diagnostics, Creative Peptides, CSBio, Enamine Ltd., GenScript Biotech Corporation, Gyros Protein Technologies AB, Hybio Pharmaceutical Co., Ltd., JPT Peptide Technologies GmbH by TheraCode GmbH, Kaneka Corporation, LifeTein LLC, Merck KGaA, New England BioGroup, LLC, Novo Nordisk A/S, PolyPeptide Group AG, Thermo Fisher Scientific Inc., and USV Private Limited.

Market Segmentation & Coverage

This research report categorizes the Peptide Synthesis Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Equipment
      • Chromatography Equipment
      • Lyophilizers
      • Peptide Synthesizers
    • Reagents
      • Amino Acids
      • Base Resins
      • Peptide Coupling Reagents
      • Peptide Labeling Reagents
    • Services
  • Technology
    • Hybrid & Recombinant Technology
    • Solid-Phase Peptide Synthesis
    • Solution-Phase Synthesis
  • End User
    • Academic & Research Institutes
    • Contract Development & Manufacturing Organization/Contract Research Organization
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Higher need and applications of peptide therapeutics
5.1.1.2. Increase in pharmaceutical research activities and funding across economies
5.1.1.3. Growing demand for bioactive peptides from the cosmetics industry
5.1.2. Restraints
5.1.2.1. Lack of standard peptide design rules and regulations
5.1.3. Opportunities
5.1.3.1. Development of advanced peptide synthesizers and technologies for peptide design
5.1.3.2. Emerging applications of peptides in nutraceuticals and food preservation
5.1.4. Challenges
5.1.4.1. Difficulty in development of peptides and instability of the peptides
5.2. Market Segmentation Analysis
5.2.1. Product: Growing usage of reagents for forming peptide bonds during synthesis
5.2.2. Technology: Rising potential of hybris & recombinant technology as it offers high peptide yield and purity
5.2.3. End-User: Expanding usage of peptide synthesis by pharmaceutical & biopharmaceutical companies for drug discovery
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Peptide Synthesis Market, by Product
6.1. Introduction
6.2. Equipment
6.2.1. Chromatography Equipment
6.2.2. Lyophilizers
6.2.3. Peptide Synthesizers
6.3. Reagents
6.3.1. Amino Acids
6.3.2. Base Resins
6.3.3. Peptide Coupling Reagents
6.3.4. Peptide Labeling Reagents
6.4. Services
7. Peptide Synthesis Market, by Technology
7.1. Introduction
7.2. Hybrid & Recombinant Technology
7.3. Solid-Phase Peptide Synthesis
7.4. Solution-Phase Synthesis
8. Peptide Synthesis Market, by End User
8.1. Introduction
8.2. Academic & Research Institutes
8.3. Contract Development & Manufacturing Organization/Contract Research Organization
8.4. Pharmaceutical & Biotechnology Companies
9. Americas Peptide Synthesis Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Peptide Synthesis Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Peptide Synthesis Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Biosynth Extends Peptide Synthesis Offering With Pepceuticals Acquisition
12.3.2. GenScript Expands Peptide Production Capabilities to Include Neoantigen Peptides and APIs
12.3.3. Mesa Labs Acquires Belyntic’s Peptide Purification Business
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. PEPTIDE SYNTHESIS MARKET RESEARCH PROCESS
FIGURE 2. PEPTIDE SYNTHESIS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 9. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. PEPTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. PEPTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. PEPTIDE SYNTHESIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. PEPTIDE SYNTHESIS MARKET DYNAMICS
TABLE 7. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CHROMATOGRAPHY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY LYOPHILIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PEPTIDE SYNTHESIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY BASE RESINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PEPTIDE COUPLING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PEPTIDE LABELING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY HYBRID & RECOMBINANT TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY SOLID-PHASE PEPTIDE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION/CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 46. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 47. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 51. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 52. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 73. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 74. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 75. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 78. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 79. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 88. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 89. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 118. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 119. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 120. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 132. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 134. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 135. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 139. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 140. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 144. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 145. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 149. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 150. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 154. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 155. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 156. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 164. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 165. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 166. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 179. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 180. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 184. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 185. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 186. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 189. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 190. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 209. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 210. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 211. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 223. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 224. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 225. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 226. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. PEPTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 238. PEPTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Peptide Synthesis market, which are profiled in this report, include:
  • 2B Scientific Limited
  • AAPPTec
  • ABclonal, Inc.
  • Advanced ChemTech
  • Almac Group Limited
  • AmbioPharm Inc.
  • AnaSpec Inc.
  • Bachem AG
  • Biocon Limited
  • Biosynth Ltd.
  • Biotage
  • CEM Corporation
  • CPC Scientific Inc.
  • Creative Diagnostics
  • Creative Peptides
  • CSBio
  • Enamine Ltd.
  • GenScript Biotech Corporation
  • Gyros Protein Technologies AB
  • Hybio Pharmaceutical Co., Ltd.
  • JPT Peptide Technologies GmbH by TheraCode GmbH
  • Kaneka Corporation
  • LifeTein LLC
  • Merck KGaA
  • New England BioGroup, LLC
  • Novo Nordisk A/S
  • PolyPeptide Group AG
  • Thermo Fisher Scientific Inc.
  • USV Private Limited

Methodology

Loading
LOADING...

Table Information